Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Infuse trimmed Axon after 80% annual returns due to valuation concerns, demonstrating disciplined selling. The fund holds a major position in an Australian pharmacy EDI company developing a marketplace platform with 10-bagger potential.
Full Quick Take
Infuse trimmed Axon after 80% annual returns due to valuation concerns, demonstrating disciplined selling. The fund holds a major position in an Australian pharmacy EDI company developing a marketplace platform with 10-bagger potential.
Ironvine's Q3 letter emphasizes management stewardship as critical to investment success, contrasting Black Knight's value-destructive governance with CoStar and Copart's exceptional leadership.
Full Quick Take
Ironvine's Q3 letter emphasizes management stewardship as critical to investment success, contrasting Black Knight's value-destructive governance with CoStar and Copart's exceptional leadership.
AVI Global Trust invests in companies trading at steep discounts to net asset value. March volatility widened portfolio discounts to 37.2%, creating buying opportunities.
Full Quick Take
AVI Global Trust invests in companies trading at steep discounts to net asset value. March volatility widened portfolio discounts to 37.2%, creating buying opportunities.